Asbestos Bailout Bill- A Trust Fund Victims Can't Trust This week, the Senate blocked the Asbestos Bailout Bill, after only 58 Senators voted to wave the Congressional Budget Act, short of the 60 required. For now, victims of asbestos and their families have retained their right to hold asbestos companies accountable for their actions.  Stay tuned for updates. Read about Charles "Joby" Sales, left, and other victims of asbestos exposure.

The Asbestos Bailout Bill was opposed by a bipartisan coalition of Senators, the AFL-CIO as well as a number of labor unions, the insurance industry, taxpayers rights' organizations, and a large number of the companies affected by the bill.

Though the bill’s supporters claimed to be working on behalf of victims, every major asbestos victims’ organization in the country opposed the bill, and last week, victims delivered more than 150,000 petition signatures to Capitol Hill to voice their opposition to the bill.

On February 2, victims of asbestos exposure came to Capitol Hill to meet with Senators and express their opposition to the Asbestos Bailout Bill.

Learn more about the Asbestos Bailout Bill.

Bush stumps for so-called medical malpractice "reform" Since the State of the Union last month, President Bush has reinforced his aims to help big drug companies, producers of faulty medical devices and bad doctors at the expense of victims hurt through no fault of their own.

Medical Malpractice "reform" has been a thematic issue for President Bush throughout his Administration. Congress is expected to take up a malpractice measure soon that will likely include benefits for the pharmaceutical and insurance industries that spend tens of millions to lobby for "tort reform," which really means taking away your rights.

Learn the facts about medical malpractice.

Tell Congress to stand up for the average person, against these powerful interests and ensure that the playing field is level.

Special Breaks for the Drug Industry - Again On the heels of enacting legislation to offer the drug industry blanket immunity during a pandemic, the administration is now attempting to provide special protections when pharmaceutical companies do not provide adquate warning labels.

The drug companies will stop at nothing to evade being held accountable when they put dangerous and deadly drugs on the market - what they couldn't get done in Congress or in the states, they're trying to accomplish through this back-door rule-making process.

Tell the FDA Commissioners that you oppose special breaks for the drug industry.